Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$27.4 million.

  • Lemaitre Vascular's Cash from Investing Activities fell 11336.29% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.0 million, marking a year-over-year decrease of 67927.62%. This contributed to the annual value of -$200.1 million for FY2024, which is 70971.07% down from last year.
  • Lemaitre Vascular's Cash from Investing Activities amounted to -$27.4 million in Q3 2025, which was down 11336.29% from -$16.3 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Cash from Investing Activities registered a high of -$402000.0 during Q4 2022, and its lowest value of -$173.9 million during Q4 2024.
  • For the 5-year period, Lemaitre Vascular's Cash from Investing Activities averaged around -$18.1 million, with its median value being -$7.2 million (2021).
  • Per our database at Business Quant, Lemaitre Vascular's Cash from Investing Activities soared by 9757.8% in 2021 and then tumbled by 759093.32% in 2024.
  • Lemaitre Vascular's Cash from Investing Activities (Quarter) stood at -$7.2 million in 2021, then skyrocketed by 94.45% to -$402000.0 in 2022, then crashed by 462.44% to -$2.3 million in 2023, then plummeted by 7590.93% to -$173.9 million in 2024, then soared by 84.22% to -$27.4 million in 2025.
  • Its last three reported values are -$27.4 million in Q3 2025, -$16.3 million for Q2 2025, and -$4.3 million during Q1 2025.